Tenax Therapeutics: Fourth Quarter Earnings Overview

Tenax Therapeutics Reports Fourth Quarter Financial Results

Tenax Therapeutics Inc., headquartered in Chapel Hill, North Carolina, announced a net loss of $15.5 million for its fourth quarter.

This translates to a loss of $0.38 per share for the quarter.

Despite the loss, the company's performance exceeded analysts' expectations, as the consensus from four analysts surveyed by Zacks Investment Research had predicted a loss of $1.26 per share.

For the full fiscal year, Tenax Therapeutics reported a total loss of $52.6 million, or $1.34 per share.